Bexagliflozin

Bexagliflozin
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alen Antony Pathil, M.D.[2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Bexagliflozin is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the treatment of Type 2 Diabetes mellitus. Common adverse reactions include female genital mycotic infections, urinary tract infection and increased urination.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Bexagliflozin FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Bexagliflozin FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Contraindications

There is limited information regarding Bexagliflozin Contraindications in the drug label.

Warnings

There is limited information regarding Bexagliflozin Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Bexagliflozin Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Bexagliflozin Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Bexagliflozin Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Bexagliflozin in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Bexagliflozin in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Bexagliflozin during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Bexagliflozin in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Bexagliflozin in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Bexagliflozin in geriatric settings.

Gender

There is no FDA guidance on the use of Bexagliflozin with respect to specific gender populations.

Race

There is no FDA guidance on the use of Bexagliflozin with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Bexagliflozin in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Bexagliflozin in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Bexagliflozin in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Bexagliflozin in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Bexagliflozin Administration in the drug label.

Monitoring

There is limited information regarding Bexagliflozin Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Bexagliflozin and IV administrations.

Overdosage

There is limited information regarding Bexagliflozin overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Bexagliflozin Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Bexagliflozin Mechanism of Action in the drug label.

Structure

There is limited information regarding Bexagliflozin Structure in the drug label.

Pharmacodynamics

There is limited information regarding Bexagliflozin Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Bexagliflozin Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Bexagliflozin Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Bexagliflozin Clinical Studies in the drug label.

How Supplied

There is limited information regarding Bexagliflozin How Supplied in the drug label.

Storage

There is limited information regarding Bexagliflozin Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Bexagliflozin |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Bexagliflozin |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Bexagliflozin Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Bexagliflozin interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Bexagliflozin Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Bexagliflozin Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.